| GOG-0239 | A Phase II Trial of AZD6244 (NSC #741078, IND #77782) in Women with Recurrent Low Grade Serous Carcinoma of the Ovary.
Click on protocol number to see eligibility requirements
Protocol Treatment Modalities:
Chemotherapy: Systemic
| Randomized: No
Principal Investigator(s):
Huyen Q. Pham
Staff Members:
Joanne Sakamoto
Grace Facio
Marissa Aldana
Yvonne Flores
|
